Comprehensive Notes on Clinical Immunology and Immunohematology

Essentials of Clinical Immunology and Immunohematology

The immune system represents the functional capacity to detect and eliminate pathogens while ensuring no harm is caused to the host. This achievement relies on a multi-layered defense architecture comprising external defenses, defenses against extracellular pathogens, and specialized defenses against intracellular pathogens. Basic structural systems, including the skin, mucosa, secretions, and the microbiota, serve as the primary external defenses. Extracellular threats are managed by cellular and humoral components like phagocytes, complement proteins, and antibodies. Intracellular threats are addressed by cytotoxic TT cells, Natural Killer (NKNK) cells, and essential cytokines such as interferons. The organization of this system is categorized into primary lymphoid organs, secondary lymphoid organs, physical barriers, and specialized immune sites.

Anatomical Organization and Lymphoid Organs

Primary lymphoid organs are the sites of immune cell production and maturation, specifically the bone marrow and the thymus. The bone marrow houses hematopoietic stem cells, which give rise to both myeloid and lymphoid progenitors. Most lymphocytes, specifically BB cells, develop here; self-reactive BB cells are either deleted or undergo receptor editing within the central glandular lymphoid organs. TT cell progenitors originate in the bone marrow but migrate to the thymus for maturation. In the thymus, nonfunctional or self-reactive TT cells are deleted, and only those that survive mature into functional, competent cells. Secondary lymphoid organs, where immune responses are activated and coordinated, include the lymph nodes, the spleen, the gut, and the mucosal-associated lymphoid tissues (MALTMALT). Additionally, specialized immune environments exist in the liver.

Innate Immunity and Physical Barriers

Innate immunity provides a rapid, non-specific response occupying the timeframe from 00 to up to 96hours96\,\text{hours} following exposure. It relies heavily on physical and chemical barriers. The skin, mucosal epithelium, cilia, and tight junctions form a physical shield. Desquamation, the continuous shedding of outer surfaces in the skin and gut, helps remove attached pathogens. Tight junctions act as zipper-like structures on the apical side of epithelial cells to prevent water loss and pathogen entry. Disruptions in these proteins increase permeability, leading to pathogen invasion, inflammation, and potential autoimmunity. Chemical defenses include gastric acid in the stomach, tears, and urine. Fluid flow in the urinary tract and eyes serves to flush contaminants, though pathogens like NeisseriagonorrhoeaeNeisseria\,gonorrhoeae utilize pilin proteins to adhere and resist flushing. Skin secretions containing lactic acid, high salt in sweat, fatty acids, and lysozyme also maintain surface hygiene.

Microbial Evasion of Innate Defenses

Pathogens have evolved diverse mechanisms to breach host barriers. StaphylococcusStaphylococcus and ClostridiumClostridium often enter through burns or cuts. Infected needles can introduce HepatitisHepatitis or HIVHIV, while arthropod bites transmit malaria, yellow fever, or protozoa like LeishmaniaLeishmania. Rabies is typically introduced via animal bites. Some bacteria produce enzymes to degrade host defenses; for instance, StreptococcusStreptococcus species secrete hyaluronidase to break down the intracellular matrix, facilitating spread. StreptococcuspneumoniaeStreptococcus\,pneumoniae produces pneumolysin, which creates pores in epithelial cells and inhibits macrophage chemotaxis. PseudomonasPseudomonas produces exosomes that degrade cell membranes, particularly problematic in cystic fibrosis. HelicobacterpyloriHelicobacter\,pylori secretes urease to neutralize the acidic pHpH of the stomach. Furthermore, ClostridiumdifficileClostridium\,difficile can bind directly to mucus to establish infection.

Microbicidal Proteins and the Complement System

Antimicrobial proteins found in the granules of granulocytes and phagocytes include defensins, lysozymes, and lactoferrin. α-defensins\alpha\text{-defensins} are primarily in neutrophils and intestinal Paneth cells, while β-defensins\beta\text{-defensins} are found in epithelia and neutrophils. Cathelicidins are present in keratinocytes and phagocytes and are released upon infection. These peptides carry a positive charge that allows them to bind and lyse cationic pathogen membranes; they also serve as chemotactic signals to recruit antigen-presenting cells (APCsAPCs). The complement system is a critical humoral component of innate immunity with three activation pathways: the classical pathway (triggered by antibodies), the lectin pathway (triggered by mannose-binding lectin recognizing microbial sugars), and the alternative pathway (a spontaneous activation by injured tissues or pathogens). All pathways converge at the cleavage of C3C3 by C3convertaseC3\,\text{convertase}. The products include C3aC3a (pro-inflammatory chemotractant) and C3bC3b (opsonin for phagocytosis). Subsequent activation of C5C5 leads to C5aC5a (inflammation) and the formation of the membrane attack complex (MACMAC, C5b9C5b-9), which causes direct pathogen lysis.

Cellular Components: The Myeloid Lineage

Myeloid progenitors in the bone marrow give rise to granulocytes and the mononuclear phagocyte system. Neutrophils are the most abundant white blood cells (70%70\%\text{ of blood cells, } 90%90\%\text{ of granulocytes}$). They are 10 to 20μm10 \text{ to } 20\,\mu m in diameter, live only 2 to 3days2 \text{ to } 3\,\text{days}, and utilize lysozyme and β-defensins\beta\text{-defensins} to kill bacteria. They can also release neutrophil extracellular traps (NETsNETs) by destroying their own nuclei. Eosinophils, distinguished by red-staining granules containing major basic protein, target extracellular parasites like helminths and possess IgEIgE receptors. Basophils (0.2%0.2\%\text{ of white blood cells}$) have dark blue-staining granules and release mediators that promote tissue destruction and allergic inflammation. Mast cells, which mature in connective and mucosal tissues, release histamine, serotonin, and inflammatory lipids like prostaglandins and leukotrienes. They express IgEIgE receptors and can cause airway constriction or fibrosis. Monocytes (10%10\%\text{ of white blood cells}$) circulate for 1 to 2days1 \text{ to } 2\,\text{days} before becoming tissue macrophages. Macrophages are highly phagocytic, can live for years, and may reach sizes of 100μm100\,\mu m. Dendritic cells (1%1\%\text{ of the system}$) are the primary link to adaptive immunity, capturing antigen and migrating to lymph nodes to activate TT cells.

Cellular Components: The Lymphoid Lineage

Lymphocytes comprise 20% to 30%20\% \text{ to } 30\%\text{ of peripheral white blood cells}. Small, non-activated lymphocytes are roughly 6μm6\,\mu m, growing to 10μm10\,\mu m when activated. The adaptive arm includes TT and BB cells. TT cells express CD3CD3, with CD4CD4 (helper) and CD8CD8 (cytotoxic) being the major subsets. CD8+CD8+ cytotoxic TT cells kill infected cells via perforins, granzymes (which kill bacterial cytoplasm), and the FasL/FasFasL/Fas pathway (activating caspase-88 for apoptosis). The innate lymphoid side includes NKNK cells and Innate Lymphoid Cells (ILCsILCs type 131-3), which represent up to 4%4\%\text{ of white blood cells}. These cells lack specific antigen receptors but provide helper functions and kill tumor or virally-infected cells.

Helper T Cell Subsets and Regulatory Mechanisms

CD4+CD4+ TT helper cells are highly versatile. Th1Th1 cells produce IFNγIFN-\gamma and TNFTNF to activate macrophages against intracellular pathogens. Th2Th2 cells produce IL4IL-4, IL15IL-15, and IL13IL-13, focusing on BB cell antibody production, allergies, and nematodes. Th9Th9 cells produce IL1βIL-1\beta, IL9IL-9, and IL21IL-21 to control responses. Th17Th17 cells produce IL17IL-17 and IL22IL-22 to recruit neutrophils against fungi and extracellular bacteria. Th22Th22 cells can induce tumor cell proliferation and migration. Follicular helper cells produce IL6IL-6 and IL21IL-21 for immune cell recruitment to tumor environments. Regulatory TT cells (TregsTregs) produce IL10IL-10 and TGFβTGF-\beta to suppress the immune response and prevent autoimmunity. Crosstalk between APCsAPCs and TT cells is mediated by molecules like B7.1B7.1 and B7.2B7.2 interacting with CD28CD28 (activation) or CTLA4CTLA-4 (inhibition). Immune checkpoints like PD1PD-1, CTLA4CTLA-4, and LAG3LAG-3 are essential for controlling the duration and intensity of the adaptive response.

B Lymphocytes and Immunoglobulin Functions

BB cells are identified by surface markers CD19CD19 and CD20CD20. Native BB cells activate and differentiate into plasma cells, which have an extensive endoplasmic reticulum for high-level antibody production. There are two main types: B1B1 cells (innate-like, found in peritoneal and pleural cavities) and B2B2 cells (conventional adaptive cells). Antibodies (IgsIgs) have a variable domain for antigen binding and a constant domain (FcFc) for effector functions. IgGIgG is the most abundant and targets bacteria. IgMIgM is the first antibody produced. IgAIgA exists as a dimer with a secretory component; IgA1IgA1 is found in serum and the upper respiratory tract, while IgA2IgA2 protects mucosal surfaces like the gut. IgEIgE is specialized for parasite defense and triggers mast cell degranulation in allergies. IgDIgD is present in trace amounts in the respiratory tract. Antibodies neutralize toxins, block microbial adhesion, immobilize flagella, and agglutinate pathogens.

Clinical Relevance and Diagnostic Immunology

Immune dysregulation leads to severe clinical consequences. Immunodeficiencies, such as SCIDSCID, the George syndrome, or HIVHIV, result in recurrent infections and can be fatal. Excessive or misdirected responses cause hypersensitivity (Type II: allergies/anaphylaxis; Type IIII: cytotoxic/hemolytic anemia; Types IIIIII and IVIV: immune complex deposition) or autoimmunity (Type 11 diabetes, Lupus Erythematosus, Multiple Sclerosis). Immunohematological issues include transfusion reactions and hemolytic disease of the newborn. Laboratory diagnostics utilize cellular analysis (flow cytometry for phenotyping, CyTOFCyTOF using rare metals), functional assays (proliferation, oxidative burst, cytotoxicity), and molecular methods (repertoire sequencing via RNASeqRNA\,Seq, qPCRqPCR, single-cell sequencing). Multiplex bead-based assays like LuminexLuminex or Mesoscale Discovery enable the profiling of over 100100 analytes from small samples, which is vital in pediatric medicine. Specific immunohematology techniques include blood typing, cross-matching via agglutination, and Tetramer technology for antigen specificity.